Gallagher Fiduciary Advisors LLC acquired a new position in shares of Merck KGaA (OTCMKTS:MKGAF – Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 5,849 shares of the company’s stock, valued at approximately $752,000.
Several other hedge funds and other institutional investors also recently made changes to their positions in the company. Pointe Capital Management LLC bought a new stake in shares of Merck KGaA during the 2nd quarter worth approximately $307,000. Western Wealth Management LLC bought a new position in Merck KGaA in the second quarter valued at approximately $1,185,000. Invst LLC acquired a new position in Merck KGaA during the second quarter valued at approximately $302,000. First Bancorp Inc ME bought a new stake in Merck KGaA during the second quarter worth $708,000. Finally, Roberts Glore & Co. Inc. IL bought a new stake in Merck KGaA during the second quarter worth $776,000. 0.10% of the stock is currently owned by institutional investors and hedge funds.
Merck KGaA Trading Up 0.3%
Shares of MKGAF stock opened at $164.00 on Wednesday. Merck KGaA has a fifty-two week low of $116.68 and a fifty-two week high of $175.56. The stock’s fifty day moving average price is $163.08 and its two-hundred day moving average price is $148.69. The company has a debt-to-equity ratio of 0.27, a quick ratio of 0.84 and a current ratio of 1.31. The company has a market cap of $21.20 billion, a PE ratio of 25.04 and a beta of 0.96.
Merck KGaA Profile
Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.
The company’s operations are organized mainly into three businesses.
Featured Articles
- Five stocks we like better than Merck KGaA
- Pathward’s Credit Scare Tests Its Comeback Story
- Wiring the AI Boom: Rumble’s $13.7B Pivot
- StoneX: Too Far Too Fast?
- DICK’s Sporting Goods Faces Pain Now for a Bigger Prize
Want to see what other hedge funds are holding MKGAF? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Merck KGaA (OTCMKTS:MKGAF – Free Report).
Receive News & Ratings for Merck KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merck KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
